07/29/10

Al Jarreau to Resume Touring on Aug. 3

Management issues statement clarifying Jarreau's situation on singer's web site

According to a statement posted on Al Jarreau's web site, the singer will resume touring on August 3 in Germany. According to his management, Jarreau did not collapse during a performance as had been reported in the international press, but rather he was feeling weak in his dressing room, hours before his performance. A doctor was called for immediately and Jarreau then went to a local hospital where he was treated for arrhythmia, a common heart-related ailment.

Al_jarreau1564_span3
Dragan Tasic

Al Jarreau

According to his management, his condition has stabilized and so they are expecting him to continue with all but a few of his upcoming dates.

Here is the statement posted on Jarreau's site about his condition and plans:

"Al Jarreau is relieved to announce plans to resume his concert tour on August 3. The concert that day will be in Hanau, Germany, at Amphitheatre Schloss Philippsruhe.

Mr. Jarreau now expects to complete the remainder of his Europe tour (Hanau and onward), and expects to be able to perform all other scheduled concerts in the USA, Japan, and elsewhere.

But, with great frustration, the singer has announced the cancellation of 3 more concerts prior to the Hanau date, following his doctors’ recommendation.

The cancelled dates are:
29 July Nuremberg, Germany, at Serenadenhof
30 July Gleisdorf, Austria, at Forum Kloster
31 July Nové Mesto nad Váhom, Slovakia, at Open Air Fest Zelena Voda

Ticketholders for these 3 cancelled concerts should contact their point of purchase – the venue box office or ticket agent.

On July 26, Al Jarreau’s medical team in Marseille performed a Catheter Ablation, to treat an arrhythmia that had recently developed. The procedure went just as the doctors hoped and expected. He moved out of the Intensive Care Unit later that day. He has been working hard to recover and prepare himself for his return to work."

Add a Comment

You need to log in to comment on this article. No account? No problem!